| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute optic neuritis: What do complementary tests add to diagnosis?
|
Fernandez, Victoria Carla
|
|
|
57 |
C |
p.
|
artikel
|
| 2 |
Age differences in trajectories of self-rated health of young people with Multiple Sclerosis
|
Ow, Nikki
|
|
|
57 |
C |
p.
|
artikel
|
| 3 |
A much needed metric: Defining reliable and statistically meaningful change of the oral version Symbol Digit Modalities Test (SDMT)
|
Strober, L.B.
|
|
|
57 |
C |
p.
|
artikel
|
| 4 |
Anti-HBs titers are not decreased after treatment with oral Cladribine in patients with Multiple Sclerosis vaccinated against Hepatitis B virus
|
Landi, Doriana
|
|
|
57 |
C |
p.
|
artikel
|
| 5 |
A proinflammatory diet is associated with an increased likelihood of first clinical diagnosis of central nervous system demyelination in women
|
Mannino, Adriana
|
|
|
57 |
C |
p.
|
artikel
|
| 6 |
AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder
|
Marignier, Romain
|
|
|
57 |
C |
p.
|
artikel
|
| 7 |
Assessment and treatment of depression in people with multiple sclerosis: A qualitative analysis of specialist clinicians’ experiences
|
Marck, Claudia H.
|
|
|
57 |
C |
p.
|
artikel
|
| 8 |
A systematic review of the effects of cannabis on cognition in people with multiple sclerosis
|
Landrigan, Jeffrey
|
|
|
57 |
C |
p.
|
artikel
|
| 9 |
A web-based life-style, exercise and activity intervention for people with progressive multiple sclerosis: Results of a single-arm feasibility study
|
Busse, Monica
|
|
|
57 |
C |
p.
|
artikel
|
| 10 |
A year with the fear of COVID-19 in multiple sclerosis patients: Examination of depression, sleep quality and quality of life before and after the pandemic
|
Yeni, Kubra
|
|
|
57 |
C |
p.
|
artikel
|
| 11 |
B-cell depleters attenuate the humoral response to SARS-CoV-2 vaccines in multiple sclerosis patients: A case-control study
|
Conte, William L.
|
|
|
57 |
C |
p.
|
artikel
|
| 12 |
Blood lactate concentrations during rest and exercise in people with Multiple Sclerosis: A systematic review and meta-analysis
|
Cerexhe, Luke
|
|
|
57 |
C |
p.
|
artikel
|
| 13 |
¿ Can COVID-19 exacerbate multiple sclerosis symptoms? A case series analysis
|
Michelena, Gloria
|
|
|
57 |
C |
p.
|
artikel
|
| 14 |
CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in multiple sclerosis
|
Baker, David
|
|
|
57 |
C |
p.
|
artikel
|
| 15 |
Changes in lymphocytes, neutrophils and immunoglobulins in year-1 cladribine treatment in multiple sclerosis
|
Spiezia, Antonio Luca
|
|
|
57 |
C |
p.
|
artikel
|
| 16 |
Characteristics of COVID-19 in patients with multiple sclerosis
|
Ghadiri, Fereshteh
|
|
|
57 |
C |
p.
|
artikel
|
| 17 |
Circulatory antioxidant and oxidative stress markers are in correlation with demographics but not cognitive functions in multiple sclerosis patients
|
Naseri, Amirreza
|
|
|
57 |
C |
p.
|
artikel
|
| 18 |
Clinical perspective on clinical outcome assessments in neurosarcoidosis
|
Moss, Brandon P
|
|
|
57 |
C |
p.
|
artikel
|
| 19 |
Comparing traditional modeling approaches versus predictive analytics methods for predicting multiple sclerosis relapse
|
Walsh, K.
|
|
|
57 |
C |
p.
|
artikel
|
| 20 |
Connection between microstructural alterations detected by diffusion MRI and cognitive dysfunction in MS: A model-free analysis approach
|
Faragó, Péter
|
|
|
57 |
C |
p.
|
artikel
|
| 21 |
Correlation of the symbol digit modalities test with the quality of life and depression in Japanese patients with multiple sclerosis
|
Niino, Masaaki
|
|
|
57 |
C |
p.
|
artikel
|
| 22 |
COVID-19 and vaccination against SARS-CoV-2 in patients with neuromyelitis optica spectrum disorders
|
Jovicevic, Vanja
|
|
|
57 |
C |
p.
|
artikel
|
| 23 |
COVID-19 infection and hospitalization rate in Iranian multiple sclerosis patients: What we know by May 2021
|
Naghavi, Saba
|
|
|
57 |
C |
p.
|
artikel
|
| 24 |
COVID-19 outcomes in persons with multiple sclerosis treated with rituximab
|
Iyer, Rajesh B
|
|
|
57 |
C |
p.
|
artikel
|
| 25 |
COVID-19 susceptibility and outcomes among patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis
|
Barzegar, Mahdi
|
|
|
57 |
C |
p.
|
artikel
|
| 26 |
COVID-19 Vaccine intent in appalachian patients with multiple sclerosis
|
Wu, Hongyan
|
|
|
57 |
C |
p.
|
artikel
|
| 27 |
Derisking CD20-therapies for long-term use
|
Smets, Ide
|
|
|
57 |
C |
p.
|
artikel
|
| 28 |
Determining the minimal important change of the 6-minute walking test in Multiple Sclerosis patients using a predictive modelling anchor-based method
|
Oosterveer, Daniëlla M
|
|
|
57 |
C |
p.
|
artikel
|
| 29 |
Diagnosis of Alzheimer's disease and related dementia among people with multiple sclerosis: Large cohort study, USA
|
Mahmoudi, Elham
|
|
|
57 |
C |
p.
|
artikel
|
| 30 |
Diagnosis of multiple sclerosis: Progress or confusion?
|
Hawkes, Christopher H
|
|
|
57 |
C |
p.
|
artikel
|
| 31 |
Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels
|
Vavasour, I.M.
|
|
|
57 |
C |
p.
|
artikel
|
| 32 |
Discontinuation of disease modifying therapies is associated with disability progression regardless of prior stable disease and age
|
Jakimovski, Dejan
|
|
|
57 |
C |
p.
|
artikel
|
| 33 |
Do Pilates exercises improve balance in patients with multiple sclerosis? A systematic review and meta-analysis
|
Arik, Meltem Isintas
|
|
|
57 |
C |
p.
|
artikel
|
| 34 |
Early treatment responses to peginterferon beta-1a are associated with longer-term clinical outcomes in patients with relapsing-remitting multiple sclerosis: Subgroup analyses of ADVANCE and ATTAIN
|
Newsome, Scott D.
|
|
|
57 |
C |
p.
|
artikel
|
| 35 |
Effect of cladribine on COVID-19 serology responses following two doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosis
|
Brill, Livnat
|
|
|
57 |
C |
p.
|
artikel
|
| 36 |
Effect of desire for pregnancy on decisions to escalate treatment in multiple sclerosis care: Differences between MS specialists and non-MS specialists
|
Saposnik, Gustavo
|
|
|
57 |
C |
p.
|
artikel
|
| 37 |
Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational study
|
Smets, Ide
|
|
|
57 |
C |
p.
|
artikel
|
| 38 |
Factors driving delayed time to multiple sclerosis diagnosis: Results from a population-based study
|
Patti, Francesco
|
|
|
57 |
C |
p.
|
artikel
|
| 39 |
Fatigue is associated with physical inactivity in people with multiple sclerosis despite different environmental backgrounds: Merging and comparing cohorts from Turkey and Israel
|
Ozdogar, Asiye Tuba
|
|
|
57 |
C |
p.
|
artikel
|
| 40 |
Human endogenous retrovirus and multiple sclerosis: A review and transcriptome findings
|
Nali, Luiz H.
|
|
|
57 |
C |
p.
|
artikel
|
| 41 |
Humoral and T-cell responses to SARS-CoV-2 vaccination in multiple sclerosis patients treated with ocrelizumab
|
Katz, J.D.
|
|
|
57 |
C |
p.
|
artikel
|
| 42 |
Humoral immune response to COVID-19 vaccines in people with secondary progressive multiple sclerosis treated with siponimod
|
Krbot Skorić, Magdalena
|
|
|
57 |
C |
p.
|
artikel
|
| 43 |
Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England
|
Garjani, Afagh
|
|
|
57 |
C |
p.
|
artikel
|
| 44 |
Implementation study of the 2021 German guideline for diagnosis and treatment of multiple sclerosis
|
Mokry, C
|
|
|
57 |
C |
p.
|
artikel
|
| 45 |
Inducing chimeric antigen receptor (CAR) regulatory T cells in-vivo: A novel concept for a potential feasible cure of demyelinating diseases
|
Sedaghat, Nahad
|
|
|
57 |
C |
p.
|
artikel
|
| 46 |
Inebilizumab for treatment of neuromyelitis optica spectrum disorder in patients with prior rituximab use from the N-MOmentum Study
|
Flanagan, Eoin P.
|
|
|
57 |
C |
p.
|
artikel
|
| 47 |
Information processing speed as a prognostic marker of physical impairment and progression in patients with multiple sclerosis
|
Hechenberger, Stefanie
|
|
|
57 |
C |
p.
|
artikel
|
| 48 |
Letter to the editor
|
Cook, Stuart D
|
|
|
57 |
C |
p.
|
artikel
|
| 49 |
Longitudinal humoral response after SARS-CoV-2 vaccination in ocrelizumab treated MS patients: To wait and repopulate?
|
van Kempen, Z.L.E.
|
|
|
57 |
C |
p.
|
artikel
|
| 50 |
Long-term dynamics of multiple sclerosis iron rim lesions
|
Weber, Claudia E.
|
|
|
57 |
C |
p.
|
artikel
|
| 51 |
Lymphopenia during treatment with dimethyl fumarate in patients with multiple sclerosis: Prevalence, predicting factors and clinical outcomes
|
Dinoto, Alessandro
|
|
|
57 |
C |
p.
|
artikel
|
| 52 |
Molecular characterization of the gut microbiome in egyptian patients with remitting relapsing multiple sclerosis
|
Mekky, Jaidaa
|
|
|
57 |
C |
p.
|
artikel
|
| 53 |
Multiple sclerosis by phenotype in Germany
|
Engelhard, Johanna
|
|
|
57 |
C |
p.
|
artikel
|
| 54 |
Myelin imaging measures as predictors of cognitive impairment in MS patients: A hybrid PET-MRI study
|
Campanholo, KR
|
|
|
57 |
C |
p.
|
artikel
|
| 55 |
Myotonometric comparison of sternocleidomastoideus and masseter muscles in multiple sclerosis patients with swallowing problem and healthy individuals
|
Maden, Tuba
|
|
|
57 |
C |
p.
|
artikel
|
| 56 |
Neuroimaging predictors of longitudinal disability and cognition outcomes in multiple sclerosis patients: A systematic review and meta-analysis
|
Pike, Ashley R.
|
|
|
57 |
C |
p.
|
artikel
|
| 57 |
Nicolau syndrome caused by Glatiramer
|
Ciprian, Sandro
|
|
|
57 |
C |
p.
|
artikel
|
| 58 |
Optical coherence tomography and visual evoked potential and its relationship with neurological disability in patients with relapsing-remitting multiple sclerosis
|
Piedrabuena, R.
|
|
|
57 |
C |
p.
|
artikel
|
| 59 |
Pediatric-onset multiple sclerosis in Poland: A registry-based retrospective cohort study
|
Brola, Waldemar
|
|
|
57 |
C |
p.
|
artikel
|
| 60 |
Performance of Activities of daily living in people with multiple sclerosis
|
Jansa, Jelka
|
|
|
57 |
C |
p.
|
artikel
|
| 61 |
Positive antithyroid antibody predicts severity of neuromyelitis optica spectrum disorder in children
|
Huo, Liang
|
|
|
57 |
C |
p.
|
artikel
|
| 62 |
Prescribing of disease modifying agents in older adults with multiple sclerosis
|
Talwar, Ashna
|
|
|
57 |
C |
p.
|
artikel
|
| 63 |
Prevalence of Multiple sclerosis and its clinical and demographic characteristics in Kurdish populations in western Iran (2020)
|
Razazian, Nazanin
|
|
|
57 |
C |
p.
|
artikel
|
| 64 |
Prevalence of trigeminal neuralgia in multiple sclerosis: A systematic review and meta-analysis
|
Houshi, Shakiba
|
|
|
57 |
C |
p.
|
artikel
|
| 65 |
Project Y: The search for clues explaining phenotype variability in MS
|
Loonstra, Floor C.
|
|
|
57 |
C |
p.
|
artikel
|
| 66 |
Quantified hemodynamic parameters of the venous system in multiple sclerosis: A systematic review
|
Bateman, Alexander Robert
|
|
|
57 |
C |
p.
|
artikel
|
| 67 |
Quantifying the relationship between disability progression and quality of life in patients treated for NMOSD: Insights from the SAkura studies
|
Levy, Michael
|
|
|
57 |
C |
p.
|
artikel
|
| 68 |
Rebound activity after fingolimod cessation: A case – control study
|
Barboza, Andres
|
|
|
57 |
C |
p.
|
artikel
|
| 69 |
Recognizing visual complaints in people with multiple sclerosis: Prevalence, nature and associations with key characteristics of MS
|
van der Feen, F.E.
|
|
|
57 |
C |
p.
|
artikel
|
| 70 |
Relationship between balance confidence and social engagement in people with multiple sclerosis
|
Judd, Grace I.
|
|
|
57 |
C |
p.
|
artikel
|
| 71 |
Relationship between lymphopenia and disease activity in persons with multiple sclerosis treated with dimethyl fumarate
|
Chu, Laura
|
|
|
57 |
C |
p.
|
artikel
|
| 72 |
Relationships between changes in daily occupations and health-related quality of life in persons with multiple sclerosis during the COVID-19 pandemic
|
Goverover, Yael
|
|
|
57 |
C |
p.
|
artikel
|
| 73 |
Resilience among older adults with multiple sclerosis: Pattern and correlates
|
Sadeghi-Bahmani, Dena
|
|
|
57 |
C |
p.
|
artikel
|
| 74 |
RETRACTED: New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19
|
Fragoso, Yara D
|
|
|
57 |
C |
p.
|
artikel
|
| 75 |
Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in the real-world setting: Interim results from the Plegridy Observational Program
|
Salvetti, Marco
|
|
|
57 |
C |
p.
|
artikel
|
| 76 |
Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection
|
Landi, Doriana
|
|
|
57 |
C |
p.
|
artikel
|
| 77 |
SARS-CoV-2 serology among people with multiple sclerosis on disease-modifying therapies after BBIBP-CorV (Sinopharm) inactivated virus vaccination: Same story, different vaccine
|
Etemadifar, Masoud
|
|
|
57 |
C |
p.
|
artikel
|
| 78 |
Serum neurofilament light chain correlates with myelin and axonal magnetic resonance imaging markers in multiple sclerosis
|
Yik, Jackie T.
|
|
|
57 |
C |
p.
|
artikel
|
| 79 |
Severe outcomes of COVID-19 among patients with multiple sclerosis under anti-CD-20 therapies: A systematic review and meta-analysis
|
Schiavetti, Irene
|
|
|
57 |
C |
p.
|
artikel
|
| 80 |
Social Cognitive Theory variables as correlates of physical activity in fatigued persons with multiple sclerosis
|
Jeng, Brenda
|
|
|
57 |
C |
p.
|
artikel
|
| 81 |
Social participation and quality of life among patients with neuromyelitis optica spectrum disorders: The mediating effects of depression
|
Wang, Tong
|
|
|
57 |
C |
p.
|
artikel
|
| 82 |
Temporal trends of multiple sclerosis disease activity: Electronic health records indicators
|
Liang, Liang
|
|
|
57 |
C |
p.
|
artikel
|
| 83 |
Teriflunomide levels in women whose male sexual partner is on teriflunomide for relapsing multiple sclerosis
|
Guarnaccia, Joseph B.
|
|
|
57 |
C |
p.
|
artikel
|
| 84 |
The association between deprivation and the access to disease modifying therapies for multiple sclerosis: An England wide community-based study in the UK MS Register
|
Das, Joyutpal
|
|
|
57 |
C |
p.
|
artikel
|
| 85 |
The ethics of prescribing low- to no-efficacy stimulants
|
Langston, Christopher
|
|
|
57 |
C |
p.
|
artikel
|
| 86 |
The evolution of multiple sclerosis in Spain over the last decade from the patient's perspective
|
Campos-Lucas, Francisco J.
|
|
|
57 |
C |
p.
|
artikel
|
| 87 |
The impact of brain lesions on sexual dysfunction in patients with multiple sclerosis: A systematic review of magnetic resonance imaging studies
|
Ramezani, Mahtab
|
|
|
57 |
C |
p.
|
artikel
|
| 88 |
The relationship between cognitive impairment, cognitive fatigue, and visual evoked potential latency in people with multiple sclerosis
|
Covey, Thomas J
|
|
|
57 |
C |
p.
|
artikel
|
| 89 |
The role of human endogenous retroviruses (HERVs) in Multiple Sclerosis and the plausible interplay between HERVs, Epstein–Barr virus infection, and vitamin D
|
Latifi, Tayebeh
|
|
|
57 |
C |
p.
|
artikel
|
| 90 |
The study of COVID-19 infection following vaccination in patients with multiple sclerosis
|
Ghadiri, Fereshteh
|
|
|
57 |
C |
p.
|
artikel
|
| 91 |
The wearing-off phenomenon of ocrelizumab in patients with multiple sclerosis
|
Toorop, A.A.
|
|
|
57 |
C |
p.
|
artikel
|
| 92 |
Treatment of myelin oligodendrocyte glycoprotein antibody associated disease with subcutaneous immune globulin
|
Sotirchos, Elias S.
|
|
|
57 |
C |
p.
|
artikel
|
| 93 |
Treatment satisfaction, safety, and tolerability of cladribine tablets in patients with highly active relapsing multiple sclerosis: CLARIFY-MS study 6-month interim analysis
|
Brochet, Bruno
|
|
|
57 |
C |
p.
|
artikel
|
| 94 |
Ultra-high field spinal cord MRI in multiple sclerosis: Where are we standing? A literature review
|
Kreiter, Daniël J.
|
|
|
57 |
C |
p.
|
artikel
|
| 95 |
Understanding the role of the blood brain barrier and peripheral inflammation on behavior and pathology on ongoing confined cortical lesions
|
Silva, Berenice Anabel
|
|
|
57 |
C |
p.
|
artikel
|
| 96 |
Utilisation of disease modifying treatment and diversity of treatment pathways in relapsing remitting multiple sclerosis
|
Hillen, J
|
|
|
57 |
C |
p.
|
artikel
|
| 97 |
Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data
|
Epstein, Samantha
|
|
|
57 |
C |
p.
|
artikel
|
| 98 |
Validation of algorithms for identifying outpatient infections in MS patients using electronic medical records
|
Smith, Jessica B.
|
|
|
57 |
C |
p.
|
artikel
|
| 99 |
Validation of MRI radiological reports in pediatric MS according to the McDonald 2017 criteria: A Danish nationwide multicenter cohort study
|
Boesen, Magnus Spangsberg
|
|
|
57 |
C |
p.
|
artikel
|
| 100 |
What is the distribution of trunk impairments and its relationship with disability level in individuals with multiple sclerosis?
|
Raats, Joke
|
|
|
57 |
C |
p.
|
artikel
|
| 101 |
White matter tracts that overlap with the thalamus and the putamen are protected against multiple sclerosis pathology
|
Clarke, M.A.
|
|
|
57 |
C |
p.
|
artikel
|
Tijdschrift beschrijving